ulipristal acetate has been researched along with Acute Liver Injury, Drug-Induced in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 9 (64.29) | 2.80 |
| Authors | Studies |
|---|---|
| Antonini, TM; Canivet, CM; Coilly, A; De Martin, E; Deback, C; Izquierdo, L; Roque-Afonso, AM | 1 |
| Capmas, P; Fernandez, H; Laberge, P; Pourcelot, AG | 1 |
| Avigan, MI; Brinker, A; Dimick-Santos, L; Jones, SC; Kang, S | 1 |
| Bucella, D; Fastrez, M; Revercez, P; Rozenberg, S; Vandromme, J | 1 |
| De Ponti, F; Gatti, M; Poluzzi, E; Raschi, E | 1 |
| Mozzanega, B | 1 |
| Yoon, EL; Yuk, JS | 1 |
| Dinis-Oliveira, RJ | 1 |
| Dinis-Oliveira, RJ; Vieira, DN | 1 |
| Donnez, J | 1 |
| Arriagada, P; Donnez, J; Larrey, D; Marciniak, M | 1 |
| Courtoy, GE; Dolmans, MM; Donnez, J | 1 |
| Conzadori, S; Greco, P; Indraccolo, U | 1 |
2 review(s) available for ulipristal acetate and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program.
Topics: Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Liver Function Tests; Norpregnadienes; Uterine Neoplasms | 2018 |
Fibroid management in premenopausal women.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hysterectomy; Leiomyoma; Norpregnadienes; Premenopause; Preoperative Care; Progesterone; Randomized Controlled Trials as Topic; Risk Factors; Uterine Neoplasms | 2019 |
12 other study(ies) available for ulipristal acetate and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic Failure.
Topics: Biomarkers; Chemical and Drug Induced Liver Injury; Cytomegalovirus; Female; Herpesvirus 6, Human; Humans; Kinetics; Liver Failure, Acute; Middle Aged; Norpregnadienes; Roseolovirus Infections | 2021 |
What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
Topics: Chemical and Drug Induced Liver Injury; Contraindications, Procedure; Female; Humans; Leiomyoma; Norpregnadienes; Risk Factors; Uterine Myomectomy; Uterine Neoplasms | 2020 |
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Norpregnadienes; Product Surveillance, Postmarketing; United States; Uterine Neoplasms | 2020 |
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
Topics: Adult; Aged; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Pandemics; Pneumonia, Viral; Risk Assessment; Risk Factors; Safety-Based Drug Withdrawals; SARS-CoV-2; Substance Withdrawal Syndrome; Uterine Neoplasms; Withholding Treatment | 2020 |
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.
Topics: Chemical and Drug Induced Liver Injury; Confounding Factors, Epidemiologic; Female; Humans; Leiomyoma; Norpregnadienes; Pharmacovigilance; Retrospective Studies; United States; Uterine Neoplasms | 2020 |
Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya.
Topics: Awareness; Chemical and Drug Induced Liver Injury; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Self Administration; Treatment Outcome | 2021 |
Use of Ulipristal Acetate and Risk of Liver Disease: A Nationwide Cohort Study.
Topics: Adult; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Incidence; Leiomyoma; Liver Diseases; Middle Aged; Norpregnadienes; Republic of Korea; Retrospective Studies; Risk Factors; Uterine Hemorrhage; Uterine Neoplasms | 2021 |
Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Norpregnadienes; Uterine Neoplasms | 2021 |
Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment?
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Liver; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Middle Aged; Norpregnadienes; Risk Assessment; Risk Factors | 2021 |
Liver injury and ulipristal acetate: an overstated tragedy?
Topics: Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Humans; Norpregnadienes; Reproduction | 2018 |
Ulipristal acetate (Esmya): restrictions on use.
Topics: Chemical and Drug Induced Liver Injury; Humans; Leiomyoma; Liver Function Tests; Norpregnadienes | 2018 |
Which is the destiny of ulipristal acetate for uterine fibroids? A commentary on the Italian medicines agency (AIFA) pronouncements
Topics: Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Female; Humans; Italy; Leiomyoma; Liver Function Tests; Norpregnadienes; Time Factors; Uterine Neoplasms | 2019 |